Literature DB >> 12663845

Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.

Helen Miles1, Sonia Johnson, Sarah Amponsah-Afuwape, Emily Finch, Morven Leese, Graham Thornicroft.   

Abstract

OBJECTIVES: The co-occurrence of severe mental illness and substance use disorder, or dual diagnosis, is prevalent and is associated with significant clinical and social problems. Most studies have treated persons with a dual diagnosis as a homogeneous population, grouping together different substances of misuse. This study investigated whether subgroups defined by their main substances of misuse were heterogeneous. The primary hypothesis was that users of stimulants, such as cocaine or amphetamines, would be characterized by especially high rates of inpatient admission, violence, and self-harm.
METHODS: Case managers' ratings were used to identify individuals with serious mental illness and comorbid substance abuse or dependence who were being treated by 13 community mental health teams in South London. Standardized instruments were used to elicit sociodemographic, clinical, social, and service use data.
RESULTS: A total of 233 cases of comorbid substance use disorder and psychotic illness were identified. On the basis of best available information, 78 (34 percent) patients were classified as alcohol misusers only, 52 (22 percent) as alcohol and cannabis users, 29 (12 percent) as users of cannabis only, and 55 (24 percent) as stimulant users; 19 patients (8 percent) were excluded from the analysis. No significant differences were found between subgroups in the use of inpatient services and lifetime history of self-harm, but there was a significant difference in lifetime history of violence, which was more frequent among stimulant users. The alcohol users were older and more likely to be white, but otherwise few differences between subgroups were suggested by exploratory analyses.
CONCLUSIONS: Apart from differences in history of violence, little heterogeneity was found among subgroups of patients with different types of substance misuse.

Entities:  

Mesh:

Year:  2003        PMID: 12663845     DOI: 10.1176/appi.ps.54.4.554

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  23 in total

Review 1.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.

Authors:  Giuseppe Carrà; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

Review 3.  Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

Authors:  David A Smelson; Lisa Dixon; Thomas Craig; Stephen Remolina; Steven L Batki; Noosha Niv; Richard Owen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.

Authors:  Adam M Leventhal; Christopher W Kahler; Lara A Ray; Kristen Stone; Diane Young; Iwona Chelminski; Mark Zimmerman
Journal:  Am J Addict       Date:  2008 May-Jun

Review 5.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Hanna Bergman; Mariam A Khokhar; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2017-01-06

6.  Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.

Authors:  Ismene L Petrakis; Charla Nich; Elizabeth Ralevski
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

7.  Characteristics of recent violence among entrants to acute mental health and substance abuse services.

Authors:  A A Mericle; B E Havassy
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05       Impact factor: 4.328

8.  Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians.

Authors:  Joshua T Kantrowitz; Karen A Nolan; Srijan Sen; Arthur A Simen; Herbert M Lachman; Malcolm B Bowers
Journal:  Psychiatr Q       Date:  2009-12

9.  Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study.

Authors:  Nanna Gilliam Toftdahl; Merete Nordentoft; Carsten Hjorthøj
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-08-11       Impact factor: 4.328

Review 10.  Marijuana Use in the Era of Changing Cannabis Laws: What Are the Risks? Who is Most at Risk?

Authors:  William V Stoecker; Emily E Rapp; Joseph M Malters
Journal:  Mo Med       Date:  2018 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.